NEWS
AI tools are the new avenue for vulnerability

By Frank Catucci, CTO and Head of Security Research, Invicti Security.

Read More
NEWS
Rise in API attacks in 2023

The State of API Security in 2024 Report highlights how APIs and their increased usage are significantly changing the threat landscape. In 2023, the number of API-targeted attacks rose significantly.

Read More
NEWS
Building a privacy-first organisation in the age of AI

By Marco Pozzoni, EMEA Storage Sales Director at Lenovo.

Read More
NEWS
Keeping Data Secure in an Increasingly Complicated World

In a world where quintillions of bytes of data are generated and collected every day, it can...

Read More
NEWS
Insights from Ransomware Preparedness: ESG Report

By Chris Rogers, Senior Technology Evangelist at Zerto, a Hewlett Packard Enterprise company.

Read More
NEWS
Mitigating the Threat of Quantum Computing

By David Corlette, VP Product Management, VIPRE Security Group.

Read More
NEWS
The end is near for the password

By Alex Laurie, SVP EMEA, Ping Identity.

Read More

Videos

News and views from the recent DCA-organised Data Centre Transformation 2024 event.
Iju Raj, Executive Vice President R&D and Simon Bennett, Director, Research and Innovation, both at AVEVA, discuss the importance of real time data analytics and how AI can help unlock access to this key...
Mat Brown, Senior Technical Marketing Engineer | Sustainability: Data Center & Hybrid Multicloud at Nutanix, who worked closely with Atlantic Ventures, as they produced the ‘Improving Sustainability in Data...
News and views from the recent DCA-organised Data Centre Transformation 2024 event.

News

The Seeq platform will be leveraged to maximize production and increase energy efficiency across the largest biorefinery in Europe.
IT teams urged to resolve ‘data delays’ as UK executives struggle to access and use relevant business data.
Architectural challenges are holding UK organisations back - with just 24% citing having sufficient governance to implement GenAI.
The promise of AI is on every biopharma’s radar, but the reality today is that much of the industry is grappling with how to convert the hype into impact.